VOR
Vor Biopharma Inc.
+0.25 (+1.14%)22.20USD575K成交股數1.3B市值0.1本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 25.9M | 17.6M | 14.1M | 261M | 26.7M | 25.3M | 21.8M | 21.8M | 24.3M | 27.6M | 23.9M | 21.9M |
| 銷售管理費用 | 21.9M | 17.6M | 14.0M | 12.8M | 6.6M | 6.0M | 6.7M | 7.2M | 8.0M | 7.7M | 8.3M | 8.5M |
| 營業利益 | −47.9M+44% | −35.2M+12% | −28.1M-1% | −274M+845% | −33.3M+3% | −31.3M-11% | −28.5M-11% | −29.0M-5% | −32.3M | −35.3M | −32.2M | −30.4M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −62.8M+93% | −220M+615% | −813M+2849% | −1.6B+5553% | −32.5M+5% | −30.7M-7% | −27.6M-8% | −27.8M-2% | −30.8M | −33.2M | −30.0M | −28.4M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -1.16-78% | -5.11-80% | -121.63+1411% | -251.24+61178% | -5.21+1058% | -25.12+5027% | -8.05+1689% | -0.41-5% | -0.45 | -0.49 | -0.45 | -0.43 |
| 稀釋股數 | 54.3M | 43.0M | 6.7M | 6.3M | 6.2M | 3.4M | 3.4M | 68.3M | 68.0M | 67.6M | 67.0M | 66.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 108M | 170M | 160M | 191M | 50.0M | 81.9M | 52.8M | 76.1M | 45.0M | 45.0M | 32.2M | 42.5M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 481M | 507M | 176M | 205M | 109M | 143M | 116M | 142M | 167M | 223M | 251M | 278M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 681M | 657M | 2.4B | 1.7B | 43.2M | 46.2M | 43.0M | 43.5M | 44.0M | 48.2M | 46.5M | 47.3M |
| 股東權益 | −200M | −150M | −2.2B | −1.5B | 66.1M | 96.7M | 73.0M | 98.1M | 123M | 175M | 204M | 230M |
| 負債比 | 141.6% | 129.7% | 1,362.8% | 833.2% | 39.6% | 32.4% | 37.1% | 30.7% | 26.3% | 21.6% | 18.5% | 17.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −38.2M | – | – | −31.1M+2% | – | – | – | −30.5M | – | – | −24.3M |
| 資本支出 | – | 48K | – | – | 231K | – | – | – | 114K | – | – | 94K |
| 自由現金流 | – | −38.3M | – | – | −31.3M+2% | – | – | – | −30.6M | – | – | −24.4M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −696M | –% | -70.50 | −144M |
| FY2024 | – | – | −117M | –% | -34.03 | −99.9M |
| FY2023 | – | – | −118M | –% | -1.75 | −101M |
| FY2022 | – | – | −92.1M | –% | -2.33 | −93.6M |
| FY2021 | – | – | −68.9M | –% | -2.10 | −73.0M |
| FY2020 | – | – | −43.3M | –% | -230.57 | −40.5M |